Publication | Open Access
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
431
Citations
29
References
2017
Year
In patients undergoing ablation for atrial fibrillation, anticoagulation with uninterrupted dabigatran was associated with fewer bleeding complications than uninterrupted warfarin. (Funded by Boehringer Ingelheim; RE-CIRCUIT ClinicalTrials.gov number, NCT02348723 .).
| Year | Citations | |
|---|---|---|
Page 1
Page 1